Delivery Order SPE2DB20D2001-SPE2DB24FM73R

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,278.85 firm fixed-price delivery order is for the supply of the medication Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $12,059.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets and has a completion date of May 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,555.04 delivery order is for the medication Myrbetriq ER 50 mg tablet, with an ultimate completion date of June 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,370.25 firm fixed-price delivery order is for the supply of 90 tablets of the medication Myrbetriq ER 50 mg. The award is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,418.22 firm fixed-price delivery order is for the provision of 30-count tablets of the drug Myrbetriq ER 25 mg. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award, valued at $15,284.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Myrbetriq ER 50 mg tablet, with an ultimate completion date of May 14, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,698.07 firm fixed-price delivery order is for 90 tablets of the medication Myrbetriq ER 50 mg. The contract has a completion date of February 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,560.78 firm fixed-price delivery order is for the supply of the medication Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.54 firm fixed-price delivery order is for the supply of the pharmaceutical product Myrbetriq ER 50 mg Tablet, with a completion date of September 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,642.98 firm fixed-price delivery order is for the pharmaceutical product MYRBETRIQ ER 50 MG TABLET 90S, with a period of performance through July 11, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM73R
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,055.53 firm fixed-price delivery order is for the medication Myrbetriq ER 50 mg tablets and has a completion date of July 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a broad range of pharmaceutical products and medical supplies to support military healthcare globally. The contract award did not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 2/27/25, 1:24 PM